Advanced bladder cancer patients could keep their bladder under new treatment regime, clinical trial shows
An approach combining chemotherapy and immunotherapy could help preserve quality of life.
Urologist Ash Tewari appointed Surgeon-in-Chief of Tisch Cancer Hospital
Ash Tewari, MBBS, MCh, is Chair of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai.
Researchers identify immune cell that helps kill bladder cancer tumors
The study also identifies potential ways to make immunotherapy more effective in this setting.
2 Commerce Drive Cranbury, NJ 08512